Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Delmas

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Virology|November 3, 2007
Genome and polypeptides characterization of Tellina virus 1 reveals a fifth genetic cluster in the Birnaviridae familyIsabelle Nobiron, Marie Galloux, Celine Henry, et al.
Vaccine|November 6, 2008
Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic siteMichelle Rémond, Bruno Da Costa, Sabine Riffault, et al.
The Journal of Biological Chemistry|May 10, 2007
Infectious bursal disease virus, a non-enveloped virus, possesses a capsid-associated peptide that deforms and perforates biological membranesMarie Galloux, Sonia Libersou, Nelly Morellet, et al.
Journal of Virology|February 12, 2002
The capsid of infectious bursal disease virus contains several small peptides arising from the maturation process of pVP2Bruno Da Costa, Christophe Chevalier, Celine Henry, et al.
The Journal of General Virology|June 15, 2017
Influenza virus protein PB1-F2 interacts with CALCOCO2 (NDP52) to modulate innate immune responseOlivier Leymarie, Léa Meyer, Lionel Tafforeau, et al.
The Journal of Biological Chemistry|November 26, 2015
Amyloid Assemblies of Influenza A Virus PB1-F2 Protein Damage Membrane and Induce CytotoxicityJasmina Vidic, Charles-Adrien Richard, Christine Péchoux, et al.
Expert Opinion on Drug Discovery|March 21, 2015
Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenzaAlexandre Monod, Christopher Swale, Bogdan Tarus, et al.
Journal of Virology|September 21, 2007
Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virusTobias Letzel, Fasseli Coulibaly, Felix A Rey, et al.
Journal of Virology|September 15, 2005
Structural peptides of a nonenveloped virus are involved in assembly and membrane translocationChristophe Chevalier, Marie Galloux, Joan Pous, et al.
Antiviral Research|October 23, 2025
Inhibition of influenza virus replication by artificial proteins (αReps) targeting its RNA-polymeraseMélissa Bessonne, Jessica Morel, Quentin Nevers, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Virology|November 3, 2007
Genome and polypeptides characterization of Tellina virus 1 reveals a fifth genetic cluster in the Birnaviridae familyIsabelle Nobiron, Marie Galloux, Celine Henry, et al.
Vaccine|November 6, 2008
Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic siteMichelle Rémond, Bruno Da Costa, Sabine Riffault, et al.
The Journal of Biological Chemistry|May 10, 2007
Infectious bursal disease virus, a non-enveloped virus, possesses a capsid-associated peptide that deforms and perforates biological membranesMarie Galloux, Sonia Libersou, Nelly Morellet, et al.
Journal of Virology|February 12, 2002
The capsid of infectious bursal disease virus contains several small peptides arising from the maturation process of pVP2Bruno Da Costa, Christophe Chevalier, Celine Henry, et al.
The Journal of General Virology|June 15, 2017
Influenza virus protein PB1-F2 interacts with CALCOCO2 (NDP52) to modulate innate immune responseOlivier Leymarie, Léa Meyer, Lionel Tafforeau, et al.
The Journal of Biological Chemistry|November 26, 2015
Amyloid Assemblies of Influenza A Virus PB1-F2 Protein Damage Membrane and Induce CytotoxicityJasmina Vidic, Charles-Adrien Richard, Christine Péchoux, et al.
Expert Opinion on Drug Discovery|March 21, 2015
Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenzaAlexandre Monod, Christopher Swale, Bogdan Tarus, et al.
Journal of Virology|September 21, 2007
Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virusTobias Letzel, Fasseli Coulibaly, Felix A Rey, et al.
Journal of Virology|September 15, 2005
Structural peptides of a nonenveloped virus are involved in assembly and membrane translocationChristophe Chevalier, Marie Galloux, Joan Pous, et al.
Antiviral Research|October 23, 2025
Inhibition of influenza virus replication by artificial proteins (αReps) targeting its RNA-polymeraseMélissa Bessonne, Jessica Morel, Quentin Nevers, et al.
Pageof 6